A new gene therapy from Bluebird Bio has helped two patients suffering from beta-thalassemia. The disorder requires blood transfusions as treatment. The gene therapy eliminated those transfusions within a 12-day period of being administered.
A new gene therapy from Bluebird Bio has helped two patients suffering from beta-thalassemia. The disorder requires blood transfusions as treatment. The gene therapy eliminated those transfusions within a 12-day period of being administered.
Share this Article
Recommended